印度和巴西签署了一项药品条例合作协议,目的是改善安全、质量和获得医疗产品的机会。 India and Brazil signed an agreement to cooperate on pharmaceutical regulations, aiming to improve safety, quality, and access to medical products.

印度和巴西签署了促进药品和医疗产品监管合作的谅解备忘录,印度的CDSCO和巴西的ANVISA建立了信息共享、监管协调和能力建设的框架。 India and Brazil have signed a Memorandum of Understanding (MoU) to boost cooperation in regulating pharmaceuticals and medical products, with India’s CDSCO and Brazil’s ANVISA establishing a framework for information sharing, regulatory alignment, and capacity building. 这项协议在巴西总统卢拉·达席尔瓦访问新德里期间在新德里签署,莫迪总理亲眼目睹,其目的是加强医疗产品的安全、质量和可及性,加强供应链,支持负担得起的医疗保健。 The agreement, signed in New Delhi during Brazilian President Lula da Silva’s visit and witnessed by Prime Minister Modi, aims to enhance the safety, quality, and accessibility of medical products, strengthen supply chains, and support affordable healthcare. 它反映了两个全球南方国家之间在以前卫生和技术协作的基础上不断加强的战略联系。 It reflects growing strategic ties between the two Global South nations, building on prior health and technology collaboration.